Salahi et al., 2022 - Google Patents
Modified red blood cells as multimodal standards for benchmarking single-cell cytometry and separation based on electrical physiologySalahi et al., 2022
View HTML- Document ID
- 3595508535371161913
- Author
- Salahi A
- Honrado C
- Rane A
- Caselli F
- Swami N
- Publication year
- Publication venue
- Analytical Chemistry
External Links
Snippet
Biophysical cellular information at single-cell sensitivity is becoming increasingly important within analytical and separation platforms that associate the cell phenotype with markers of disease, infection, and immunity. Frequency-modulated electrically driven microfluidic …
- 210000003324 RBC 0 title abstract description 211
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N2015/0065—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials biological, e.g. blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Salahi et al. | Modified red blood cells as multimodal standards for benchmarking single-cell cytometry and separation based on electrical physiology | |
Spencer et al. | High-speed single-cell dielectric spectroscopy | |
Zhou et al. | Characterizing deformability and electrical impedance of cancer cells in a microfluidic device | |
Holmes et al. | Single cell impedance cytometry for identification and counting of CD4 T-cells in human blood using impedance labels | |
Feng et al. | A microfluidic device integrating impedance flow cytometry and electric impedance spectroscopy for high-efficiency single-cell electrical property measurement | |
Mansor et al. | Single cell electrical characterization techniques | |
Turcan et al. | Dielectrophoretic manipulation of cancer cells and their electrical characterization | |
Chen et al. | Microfluidic impedance flow cytometry enabling high-throughput single-cell electrical property characterization | |
Schröder et al. | Combined dielectrophoresis–Raman setup for the classification of pathogens recovered from the urinary tract | |
Witek et al. | Cell separations and sorting | |
Zhu et al. | Microfluidic impedance cytometry for single-cell sensing: Review on electrode configurations | |
Adamo et al. | Microfluidics-based assessment of cell deformability | |
Hoettges et al. | Dielectrophoresis-activated multiwell plate for label-free high-throughput drug assessment | |
Crowell et al. | Electrical impedance spectroscopy for monitoring chemoresistance of cancer cells | |
Primiceri et al. | Cell chips as new tools for cell biology–results, perspectives and opportunities | |
Das et al. | Dielectrophoretic segregation of different human cell types on microscope slides | |
Rohani et al. | Label-free quantification of intracellular mitochondrial dynamics using dielectrophoresis | |
Liang et al. | Single-cell stretching in viscoelastic fluids with electronically triggered imaging for cellular mechanical phenotyping | |
Antunez-Vela et al. | Simultaneous determination of linear and nonlinear electrophoretic mobilities of cells and microparticles | |
Srivastava et al. | Dielectrophoretic characterization of erythrocytes: Positive ABO blood types | |
Shukla et al. | Lab-on-a-chip platforms for biophysical studies of cancer with single-cell resolution | |
Yin et al. | Detection of circulating tumor cells by fluorescence microspheres-mediated amplification | |
Wlodkowic et al. | Apoptosis goes on a chip: advances in the microfluidic analysis of programmed cell death | |
Wang et al. | Characterizing the heterogeneity of small extracellular vesicle populations in multiple cancer types via an ultrasensitive chip | |
Schütt et al. | Nanocytometer for smart analysis of peripheral blood and acute myeloid leukemia: A pilot study |